StudyHub

Psychosis in the Pediatric Population

Research psychosis in the pediatric population and discuss symptoms and diagnoses that relate to this population. Make sure to include epidemiology and risk factors that children have for certain psychotic disorders. Discuss treatment options for these patients. Be sure to include ethical considerations in the diagnosis and treatment of psychosis.

Struggling with where to start this assignment? Follow this guide to tackle your assignment easily!

Tutor’s Step-by-Step Writing Guide

1) Introduction (1 short paragraph)

• Define pediatric psychosis in clear terms (loss of contact with reality with symptoms such as hallucinations, delusions, and disorganized behavior/thought).

• State your paper’s purpose: to summarize symptoms and differential diagnoses, review epidemiology and risk factors, outline evidence-based treatments, and address ethical considerations.

2) Epidemiology (≈1–2 paragraphs)

• Report estimated prevalence and typical age of onset: distinguish childhood-onset schizophrenia (COS; onset <13 years, very rare) from early-onset (adolescence) and brief/transient psychotic episodes.

• Note sex patterns (e.g., earlier adolescent onset more common in males) and course (chronic vs. episodic).

• Include data on healthcare utilization/impairment (school functioning, hospitalization).

• Tip: Use recent national or guideline sources; cite exact stats with year.

3) Risk Factors (≈1–2 paragraphs, use bullets for clarity)
Group risks into biological, developmental, and environmental:

• Biological/Genetic: family history of schizophrenia or bipolar disorder; copy-number variants (e.g., 22q11.2 deletion); perinatal complications; neurodevelopmental disorders.

• Developmental: language/motor delays; social-communication difficulties; premorbid cognitive impairment; substance use (notably cannabis in adolescence).

• Environmental/Psychosocial: trauma/adversity, immigration-related stress, urbanicity, sleep disturbance; medical causes (autoimmune encephalitis, epilepsy, metabolic disorders) and iatrogenic causes (steroids, stimulants in rare cases, anticholinergics).

4) Clinical Presentation: Symptoms & Differential Diagnosis (≈2–3 paragraphs)

• Core psychotic symptoms: auditory hallucinations (most common), visual/tactile less common; delusions; disorganized thinking/speech; negative symptoms (avolition, flat affect).

• Developmental context: differentiate fantasy/imaginary friends and anxiety-related phenomena from true psychosis; consider cultural beliefs.

• Differential diagnoses to rule out:

  • Mood disorders with psychotic features (MDD or bipolar).

  • Autism spectrum disorder (misinterpreted unusual speech/behaviors).

  • Trauma- and stressor-related disorders (dissociation, hypervigilance).

  • Substance/medication-induced (cannabis, dextromethorphan, steroids).

  • Medical/neurologic (delirium, seizures, autoimmune encephalitis, thyroid/B12, Wilson disease, porphyria, infections).

  • Obsessive-compulsive disorder, severe anxiety, PANDAS/PANS (controversial—apply rigorous medical workup).

5) Assessment & Workup (use a concise checklist)

• History/Exam: onset/timeline, stressors, substances, sleep, developmental and family history; full neurologic exam and vitals.

• Screening labs: CBC, CMP, thyroid panel, B12/folate, urine toxicology; consider ANA/ESR/CRP, infectious tests as indicated.

• Further testing if red flags: EEG, MRI, autoimmune encephalitis panel, metabolic studies.

• Rating tools: PANSS (adapted), BPRS-C, SIPS for prodromal risk (specialist use).

• Risk & safety: suicide risk, command hallucinations, ability to care for self; crisis/safety plan.

6) Diagnosis (structure with subheads)

• Apply DSM-5-TR criteria for schizophrenia spectrum and other psychotic disorders (brief psychotic disorder, schizophreniform, schizophrenia, schizoaffective), or mood disorders with psychotic features.

• Clearly justify diagnosis after ruling out medical/substance causes and differentials.

7) Treatment Options (evidence-informed, multimodal)

• First-line nonpharmacologic (always include):

  • Psychoeducation (patient/family), family-focused therapy, CBT for psychosis (CBT-p), school accommodations/IEP, sleep hygiene, substance-use counseling.

  • Coordinated Specialty Care (CSC)/Early Intervention programs for first-episode psychosis (multidisciplinary).

• Pharmacotherapy:

  • Second-generation antipsychotics commonly used in youth (e.g., risperidone, aripiprazole, olanzapine, quetiapine). Start low, go slow; monitor metabolic and extrapyramidal side effects.

  • Clozapine for treatment-resistant cases (after 2 adequate trials), with REMS monitoring (agranulocytosis, myocarditis, seizures).

  • Address comorbid depression/anxiety (psychotherapy first; SSRIs cautiously if indicated), ADHD (optimize psychosis first; careful stimulant use).

• Monitoring & Safety: baseline and periodic BMI/weight, waist, BP, fasting glucose/A1c, lipids, EPS/akathisia scales (AIMS), prolactin if symptomatic; labs more frequently early in treatment.

• Adjuncts: omega-3s (mixed evidence), exercise interventions, social skills training, cognitive remediation.

8) Ethical Considerations (integrate throughout; add a focused paragraph)

• Informed consent/assent: developmentally appropriate explanations; involve guardians while preserving adolescent autonomy.

• Stigma & labeling: avoid premature diagnosis; use watchful waiting when appropriate; document diagnostic uncertainty transparently.

• Risk–benefit with antipsychotics: weigh metabolic/cardiovascular risks against symptom control and functional recovery; shared decision-making.

• Equity & access: ensure culturally sensitive assessment; interpreter use; address disparities in early-psychosis services.

• Safety & confidentiality: suicide/violence risk management; school coordination while protecting privacy (FERPA/HIPAA considerations).

9) Conclusion (1 short paragraph)

• Reiterate the need for thorough medical rule-out, developmentally sensitive assessment, family-centered psychosocial care, cautious pharmacotherapy, and ethical, shared decision-making to optimize outcomes.

10) Quick Outline You Can Mirror in Your Paper

• Introduction

• Epidemiology

• Risk Factors

• Symptoms & Differential Diagnosis

• Assessment & Workup

• Diagnosis (DSM-5-TR)

• Treatment (psychosocial + pharmacologic + monitoring)

• Ethical Considerations

• Conclusion

High-Quality Resource Links (guidelines & reviews)

• NIMH – Children and Mental Health (Psychosis/Schizophrenia in Children & Teens): https://www.nimh.nih.gov/health/topics/schizophrenia

• AACAP Practice Parameter – Schizophrenia in Children & Adolescents: https://www.jaacap.org/article/S0890-8567(13)00997-4/fulltext

• NICE Guideline – Psychosis and Schizophrenia in Children and Young People (CG155): https://www.nice.org.uk/guidance/cg155

• WHO mhGAP – Psychosis in Children/Adolescents (intervention guide): https://www.who.int/teams/mental-health-and-substance-use/treatment-care/mhgap

• Cochrane – Antipsychotics for early-onset schizophrenia (evidence reviews): https://www.cochranelibrary.com/

• Royal College of Psychiatrists – Psychosis & Schizophrenia in Children/Young People (patient-friendly): https://www.rcpsych.ac.uk/mental-health/parents-and-young-people

• APA DSM-5-TR (overview): https://www.psychiatry.org/psychiatrists/practice/dsm

• SAMHSA – First Episode Psychosis & Coordinated Specialty Care: https://www.samhsa.gov/behavioral-health/early-serious-mental-illness/first-episode-psychosis

The post Pediatric Psychosis: Symptoms, Diagnosis, Epidemiology, Risk Factors, and Treatment appeared first on Skilled Papers.